Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study - Concepedia

Concepedia

Publication | Open Access

Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study

DOI Full Paper Access

20

Citations

19

References

2023

Year

Winsley Rose, Reshma Raju, Sudhir Babji, Anna George, Ramya Madhavan, Julian Vivek Leander Xavier, Jenita Sharon David Chelladurai, Origanti Sharon Nikitha, Arpitha Anbu Deborah, Shalini Vijayakumar,

The Lancet Regional Health - Southeast Asia

References

	Year	Citations

Page 1